MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, MDGL made $958,403K in revenue. -$288,284K in net income. Net profit margin of -30.08%.

Income Overview

Revenue
$958,403K
Net Income
-$288,284K
Net Profit Margin
-30.08%
EPS
-$12.85
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-31
Product revenue, net
958,403
Cost of sales
56,148
Research and development
388,525
Selling, general and administrative
813,827
Total operating expenses
1,258,500
Loss from operations
-300,097
Interest income
37,364
Interest expense
22,309
Loss on extinguishment of debt
-2,779
Other expense, net
-463
Net loss
-288,284
Basic net loss per common share (in dollars per share)
-12.85
Basic weighted average number of common shares outstanding (in shares)
22,434,310
Diluted net loss per common share (in dollars per share)
-12.85
Diluted weighted average number of common shares outstanding (in shares)
22,434,310
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$288,284K Interest income$37,364K Other expense, net-$463K Loss onextinguishment of debt-$2,779K Interest expense$22,309K Loss from operations-$300,097K Product revenue, net$958,403K Total operatingexpenses$1,258,500K Selling, general andadministrative$813,827K Research and development$388,525K Cost of sales$56,148K

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

MADRIGAL PHARMACEUTICALS, INC. (MDGL)